The risk of the hemolytic-uremic syndrome after antibiotic treatment of Escherichia coli O157:H7 infections
- PMID: 10874060
- PMCID: PMC3659814
- DOI: 10.1056/NEJM200006293422601
The risk of the hemolytic-uremic syndrome after antibiotic treatment of Escherichia coli O157:H7 infections
Abstract
Background: Children with gastrointestinal infections caused by Escherichia coli O157:H7 are at risk for the hemolytic-uremic syndrome. Whether antibiotics alter this risk is unknown.
Methods: We conducted a prospective cohort study of 71 children younger than 10 years of age who had diarrhea caused by E. coli O157:H7 to assess whether antibiotic treatment in these children affects the risk of the hemolytic-uremic syndrome and to assess the influence of confounding factors on this outcome. Estimates of relative risks were adjusted for possible confounding effects with the use of logistic-regression analysis.
Results: Among the 71 children, 9 (13 percent) received antibiotics and the hemolytic-uremic syndrome developed in 10 (14 percent). Five of these 10 children had received antibiotics. Factors significantly associated with the hemolytic-uremic syndrome were a higher initial white-cell count (relative risk, 1.3; 95 percent confidence interval, 1.1 to 1.5), evaluation with stool culture soon after the onset of illness (relative risk, 0.3; 95 percent confidence interval, 0.2 to 0.8), and treatment with antibiotics (relative risk, 14.3; 95 percent confidence interval, 2.9 to 70.7). The clinical and laboratory characteristics of the 9 children who received antibiotics and the 62 who did not receive antibiotics were similar. In a multivariate analysis that was adjusted for the initial white-cell count and the day of illness on which stool was obtained for culture, antibiotic administration remained a risk factor for the development of the hemolytic uremic syndrome (relative risk, 17.3; 95 percent confidence interval, 2.2 to 137).
Conclusions: Antibiotic treatment of children with E. coli O157:H7 infection increases the risk of the hemolytic-uremic syndrome.
Comment in
-
E. coli, antibiotics, and the hemolytic-uremic syndrome.N Engl J Med. 2000 Jun 29;342(26):1990-1. doi: 10.1056/NEJM200006293422611. N Engl J Med. 2000. PMID: 10874069 No abstract available.
-
Risk of the hemolytic-uremic syndrome after antibiotic treatment of Escherichia coli O157:H7 infections.N Engl J Med. 2000 Oct 26;343(17):1271-2; author reply 1272-3. doi: 10.1056/NEJM200010263431716. N Engl J Med. 2000. PMID: 11183357 No abstract available.
-
Risk of the hemolytic-uremic syndrome after antibiotic treatment of Escherichia coli O157:H7 infections.N Engl J Med. 2000 Oct 26;343(17):1271; author reply 1272-3. N Engl J Med. 2000. PMID: 11183358 No abstract available.
References
-
- Bell BP, Griffin PM, Lozano P, Christie DL, Kobayashi JM, Tarr PI. Predictors of hemolytic uremic syndrome in children during a large outbreak of Escherichia coli O157:H7 infections. Pediatrics. 1997;100:127. abstract. (See http://www.pediatrics.org/cgi/content/full/100/1/e12.) - PubMed
-
- Tarr PI, Neill MA, Clausen CR, Watkins SL, Christie DL, Hickman RO. Escherichia coli O157:H7 and the hemolytic uremic syndrome: importance of early cultures in establishing the etiology. J Infect Dis. 1990;162:553–6. - PubMed
-
- Ostroff SM, Kobayashi JM, Lewis JH. Infections with Escherichia coli O157:H7 in Washington State: the first year of statewide disease surveillance. JAMA. 1989;262:355–9. - PubMed
-
- Rowe P, Orrbine E, Lior H, et al. Risk of hemolytic uremic syndrome after sporadic Escherichia coli O157:H7 infection: results of a Canadian collaborative study. J Pediatr. 1998;132:777–82. - PubMed
-
- Karmali MA, Steele BT, Petric M, Lim C. Sporadic cases of haemolytic-uraemic syndrome associated with faecal cytotoxin and cytotoxin-producing Escherichia coli in stools. Lancet. 1983;1:619–20. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical